Kck Ltd. sold $50M of NPCE
owner at NeuroPace Inc. 5,270,845 shares at an average of $9.40, traded Feb 20, 2025, filed Feb 20, 2025.
Score components
- +12Role10% owner
- +25Trade size$49.5M at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -15.5%, 3m +25.6%, 6m -39.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001657662-25-000003, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 20, 2025 | SOpen-market sale Common Stock | -5,270,845 | $9.40 | $50M | 0 | Feb 20, 2025 |
Related signals
Other insiders at NeuroPace Inc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 21Weak | NeuroPace Inc | Martha Morrell CHIEF MEDICAL OFFICER | $399k 25,000 shares | -33% | |
| 37Weak | NPCEsell NeuroPace Inc | Orbimed Advisors LLC owner | $2.7M 168,136 shares | -5% | |
| 37Weak | NPCEsell NeuroPace Inc | Kck Ltd. owner | $1.2M 224,138 shares | -4% | |
| 12Weak | NPCEsell NeuroPace Inc | Kck Ltd. owner | $25k 4,082 shares | -0% | |
| 19Weak | NPCEsell NeuroPace Inc | Kck Ltd. owner | $53k 8,598 shares | -0% | |
| 26Weak | NPCEsell NeuroPace Inc | Kck Ltd. owner | $303k 46,426 shares | -1% | |
| 13Weak | NeuroPace Inc | Martha Morrell Chief Medical Officer | $265k 17,589 shares | -18% | |
| 12Weak | NeuroPace Inc | Martha Morrell Chief Medical Officer | $209k 13,848 shares | -13% | |
| 0Weak | NeuroPace Inc | Martha Morrell Chief Medical Officer | $12k 828 shares | -1% | |
| 11Weak | NeuroPace Inc | Martha Morrell Chief Medical Officer | $136k 13,402 shares | -11% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.